XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
IPO
Common stock
Common stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020     61,321,424          
Beginning balance at Dec. 31, 2020 $ 470,150   $ 613   $ 492,747   $ 78 $ (23,288)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 2,073       2,073      
Foreign currency translation adjustments (12)           (12)  
Issuance of common stock to board of director member (in shares)     25,200          
Issuance of common stock to a board of directors member 250       250      
Issuance of common stock in initial public offering, net of issuance costs (in shares)       11,666,667        
Issuance of common stock in initial public offering, net of issuance costs   $ 146,136   $ 117   $ 146,019    
Dividend (74,500)       (74,500)      
Net income (loss) (14,077)             (14,077)
Ending balance (in shares) at Jun. 30, 2021     73,013,291          
Ending balance at Jun. 30, 2021 530,020   $ 730   566,589   66 (37,365)
Beginning balance (in shares) at Mar. 31, 2021     61,321,424          
Beginning balance at Mar. 31, 2021 395,699   $ 613   419,237   71 (24,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 1,083       1,083      
Foreign currency translation adjustments (5)           (5)  
Issuance of common stock to board of director member (in shares)     25,200          
Issuance of common stock to a board of directors member 250       250      
Issuance of common stock in initial public offering, net of issuance costs (in shares)       11,666,667        
Issuance of common stock in initial public offering, net of issuance costs   $ 146,136   $ 117   $ 146,019    
Net income (loss) (13,143)             (13,143)
Ending balance (in shares) at Jun. 30, 2021     73,013,291          
Ending balance at Jun. 30, 2021 530,020   $ 730   566,589   66 (37,365)
Beginning balance (in shares) at Dec. 31, 2021     73,194,171          
Beginning balance at Dec. 31, 2021 537,749   $ 732   570,252   31 (33,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 4,130       4,130      
Foreign currency translation adjustments (72)           (72)  
Issuance of share of common stock with respect to vested restricted stock units, net of 11,121 shares valued at $144,573 tendered for tax withholding (in shares)     27,451          
Issuance of shares of common stock with respect to vested restricted stock units, net of 10,947 shares valued at forty-three thousand dollars tendered for tax withholding (43)       (43)      
Net income (loss) (11,044)             (11,044)
Ending balance (in shares) at Jun. 30, 2022     73,221,622          
Ending balance at Jun. 30, 2022 530,720   $ 732   574,339   (41) (44,310)
Beginning balance (in shares) at Mar. 31, 2022     73,194,171          
Beginning balance at Mar. 31, 2022 537,845   $ 732   571,516   17 (34,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 2,866       2,866      
Foreign currency translation adjustments (58)           (58)  
Issuance of share of common stock with respect to vested restricted stock units, net of 11,121 shares valued at $144,573 tendered for tax withholding (in shares)     27,451          
Issuance of shares of common stock with respect to vested restricted stock units, net of 10,947 shares valued at forty-three thousand dollars tendered for tax withholding (43)       (43)      
Net income (loss) (9,890)             (9,890)
Ending balance (in shares) at Jun. 30, 2022     73,221,622          
Ending balance at Jun. 30, 2022 $ 530,720   $ 732   $ 574,339   $ (41) $ (44,310)